Professor Peter Ferdinandy

Péter Ferdinandy, MD, PhD, MBA, FESC, FISHR has been recognized as Highly Cited Researcher in 2014, 2017, 2020, 2021, and 2022. He published more than 400 papers and 6 patent families. His work is cited more than 28000 times and his Hirsh index is 85. He received an MD diploma in 1991, a PhD in 1995, and an MBA in finance and quality management in 2004. He became a registered clinical pharmacologist in 1999. He did a postdoctoral training at the University of Alberta, Edmonton, Canada (1997-1999). He founded Pharmahungary Group, a group of R&D companies (www.pharmahungary.com) involved in more than 350 drug/medical device development projects since their foundation in the early 2000s. Currently he is the director of the Department of Pharmacology and Pharmacotherapy, the vice-rector for science and innovations, Semmelweis University, Budapest, Hungary (www.semmelweis.hu). He is the editor-in-chief of the British Journal of Pharmacology since 2023.